Search

everythinglearnresearchcommunity

for

Search:↓

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Porcine placenta extract may improve hair growth and skin health.

A standardized consent form for PRP injections improves patient trust and legal protection.

Apremilast may help treat hair loss in alopecia areata.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Standardized protocols are crucial for effective use of platelet-rich plasma and fibrin in tissue regeneration.

Tadalafil and Finasteride may help treat aggressive melanoma.

The study suggests that a new protease inhibitor can make hair harder to pull out, potentially reducing hair loss.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Blocking a protein called prostaglandin D2 might help treat hair loss.

PDRN is effective and safe for healing wounds and skin issues.

A new method improves platelet testing for heart disease patients.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

IL-1β inhibits human hair follicle growth.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Invasomes loaded with clotrimazole gel could improve drug delivery through the skin for fungal treatment.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.